Episode summary: Antidepressants like SSRIs and Strattera don't just fix a "chemical imbalance" — they trigger a months-long process of structural brain remodeling, from new dendritic spines to adult neurogenesis. This episode breaks down the molecular cascade from serotonin to BDNF to new neural growth, the three major brain networks that physically change during treatment, and the uncomfortable asymmetry: it takes weeks to build new connections but only days for them to retract after withdrawal. We explore what that means for relapse rates, informed consent, and whether the positive changes can ever last. Show Notes The human brain contains roughly 86 billion neurons and 100 trillion synapses. When someone takes an SSRI for six to eight weeks, trillions of molecular events unfold across multiple brain regions — and the brain is literally physically remodeled. The drug blocks serotonin reuptake, which activates 5-HT4 and 5-HT1A receptors, triggering a signaling cascade that boosts CREB and ultimately drives BDNF (brain-derived neurotrophic factor) expression. BDNF promotes dendritic spine growth, synaptic strengthening, and even adult neurogenesis in the hippocampus. Remarkably, Strattera (atomoxetine) achieves the same endpoint through a different pathway — norepinephrine reuptake inhibition that also converges on CREB and BDNF. Three major brain networks shift measurably after weeks of treatment: the default mode network quiets down (reducing rumination), fronto-limbic connectivity strengthens (improving emotional regulation), and amygdala reactivity to negative stimuli diminishes. These structural changes map directly onto the clinical picture of depression remission. But here's the brutal asymmetry: when the drug is withdrawn, dendritic spines retract within one to two weeks — faster than the three to four weeks it took to build them. Active pruning mechanisms, including microglial engulfment and LTD-like processes, drive the reversal. The brain actively re-establishes its original homeostatic set point, which for someone with depression is a state of lower BDNF and reduced connectivity. Relapse rates within six to twelve months of discontinuation run 60-80%. The episode explores whether any positive changes can be preserved through state-dependent plasticity — the idea that the drug opens a window for learning, and what gets built during that window may outlast the drug itself. Listen online: https://myweirdprompts.com/episode/ssri-brain-rewiring-reversal